Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patients.

In conclusion, the association between TNBC and COX-2 overexpression in operable breast cancer supports further investigation into COX-2-targeted therapy for patients with TNBC.
PMID: 25054056 [PubMed - as supplied by publisher]

Source: Clinical Breast Cancer - July 28, 2014 Category: Cancer & Oncology Authors: Mosalpuria K, Hall C, Krishnamurthy S, Lodhi A, Hallman DM, Baraniuk MS, Bhattacharyya A, Lucci A Tags: Mol Clin Oncol Source Type: research